25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ASMB (Assembly Biosciences Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Assembly Biosciences Inc together

I guess you are interested in Assembly Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Assembly Biosciences Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Assembly Biosciences Inc’s Price Targets

I'm going to help you getting a better view of Assembly Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Assembly Biosciences Inc

I send you an email if I find something interesting about Assembly Biosciences Inc.

1. Quick Overview

1.1. Quick analysis of Assembly Biosciences Inc (30 sec.)










1.2. What can you expect buying and holding a share of Assembly Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$3.55
Expected worth in 1 year
$2.84
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-0.72
Return On Investment
-3.8%

For what price can you sell your share?

Current Price per Share
$18.75
Expected price per share
$14.80 - $20.04
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Assembly Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)
$18.75
Intrinsic Value Per Share
$-141.73 - $-66.32
Total Value Per Share
$-138.18 - $-62.77

2.2. Growth of Assembly Biosciences Inc (5 min.)




Is Assembly Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$27.1m$42.5m-$12.2m-40.6%

How much money is Assembly Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$9.9m-$12.8m$2.8m28.7%
Net Profit Margin-126.3%-77.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Assembly Biosciences Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#473 / 872

Most Revenue
#310 / 872

Most Profit
#521 / 872

Most Efficient
#534 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Assembly Biosciences Inc?

Welcome investor! Assembly Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Assembly Biosciences Inc.

First you should know what it really means to hold a share of Assembly Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Assembly Biosciences Inc is $18.75. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Assembly Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Assembly Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.55. Based on the TTM, the Book Value Change Per Share is $-0.18 per quarter. Based on the YOY, the Book Value Change Per Share is $-1.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Assembly Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.15-6.2%-1.31-7.0%-1.68-9.0%-1.53-8.2%-1.13-6.1%-0.93-5.0%
Usd Book Value Change Per Share-0.82-4.3%-0.18-1.0%-1.24-6.6%0.040.2%-0.18-1.0%-0.19-1.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.82-4.3%-0.18-1.0%-1.24-6.6%0.040.2%-0.18-1.0%-0.19-1.0%
Usd Price Per Share9.56-13.55-4.04-6.35-6.92-13.93-
Price to Earnings Ratio-2.07--2.59--0.80--1.30--1.89--5.93-
Price-to-Total Gains Ratio-11.73-10.42--5.80-0.85--79.95--51.29-
Price to Book Ratio2.69-3.44-0.90-1.60-1.45-2.75-
Price-to-Total Gains Ratio-11.73-10.42--5.80-0.85--79.95--51.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share18.75
Number of shares53
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.18-0.18
Usd Total Gains Per Share-0.18-0.18
Gains per Quarter (53 shares)-9.49-9.60
Gains per Year (53 shares)-37.94-38.42
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-38-480-38-48
20-76-860-77-86
30-114-1240-115-124
40-152-1620-154-162
50-190-2000-192-200
60-228-2380-231-238
70-266-2760-269-276
80-304-3140-307-314
90-342-3520-346-352
100-379-3900-384-390

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%1.039.00.02.5%1.064.01.01.5%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%5.015.00.025.0%8.032.00.020.0%14.049.03.021.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.066.00.0%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%5.015.00.025.0%8.032.00.020.0%14.049.03.021.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Assembly Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.815-0.179-78%-1.235+52%0.042-2047%-0.181-78%-0.190-77%
Book Value Per Share--3.5533.966-10%5.576-36%5.240-32%5.353-34%5.711-38%
Current Ratio--2.0492.390-14%5.164-60%4.993-59%8.093-75%10.174-80%
Debt To Asset Ratio--0.7260.721+1%0.449+62%0.443+64%0.311+133%0.286+154%
Debt To Equity Ratio--2.6492.601+2%1.368+94%1.386+91%0.883+200%0.651+307%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--92158978.000127160552.500-28%66863096.001+38%107732309.990-14%250701305.017-63%392509483.669-77%
Eps---1.155-1.307+13%-1.681+46%-1.529+32%-1.135-2%-0.930-19%
Ev To Ebitda Ratio---2.325-2.844+22%-1.330-43%-1.858-20%-2.611+12%-5.358+130%
Ev To Sales Ratio--2.4464.080-40%3.451-29%3.870-37%14.804-83%40.463-94%
Free Cash Flow Per Share---3.069-1.840-40%0.901-440%-0.845-72%-0.699-77%-0.586-81%
Free Cash Flow To Equity Per Share---2.817-0.813-71%1.207-333%-0.346-88%-0.326-88%118.226-102%
Gross Profit Margin--1.0001.0010%1.0030%1.0010%1.0010%1.0000%
Intrinsic Value_10Y_max---66.320----------
Intrinsic Value_10Y_min---141.731----------
Intrinsic Value_1Y_max---2.973----------
Intrinsic Value_1Y_min---5.251----------
Intrinsic Value_3Y_max---11.731----------
Intrinsic Value_3Y_min---23.624----------
Intrinsic Value_5Y_max---23.864----------
Intrinsic Value_5Y_min---50.455----------
Market Cap143204062.500+49%73014978.000103488802.500-29%30846346.001+137%61213309.990+19%157037905.017-54%306256262.869-76%
Net Profit Margin---0.936-1.263+35%-0.775-17%-0.679-27%-2.454+162%-3.418+265%
Operating Margin---1.055-1.413+34%-0.902-15%-0.772-27%-2.512+138%-3.556+237%
Operating Ratio--2.0552.414-15%1.402+47%1.272+62%4.590-55%6.810-70%
Pb Ratio5.278+49%2.6913.443-22%0.898+200%1.597+68%1.452+85%2.750-2%
Pe Ratio-4.060-96%-2.070-2.585+25%-0.797-62%-1.302-37%-1.894-9%-5.928+186%
Price Per Share18.750+49%9.56013.550-29%4.039+137%6.353+50%6.920+38%13.934-31%
Price To Free Cash Flow Ratio-1.527-96%-0.779-19.559+2411%-0.410-47%-6.874+783%-4.389+464%-6.302+709%
Price To Total Gains Ratio-23.001-96%-11.72710.422-213%-5.797-51%0.847-1485%-79.951+582%-51.293+337%
Quick Ratio--3.4024.001-15%7.965-57%7.472-54%12.637-73%15.643-78%
Return On Assets---0.089-0.092+3%-0.172+93%-0.154+73%-0.135+51%-0.113+27%
Return On Equity---0.325-0.332+2%-0.300-8%-0.289-11%-0.221-32%-0.177-45%
Total Gains Per Share---0.815-0.179-78%-1.235+52%0.042-2047%-0.181-78%-0.190-77%
Usd Book Value--27133000.00030294250.000-10%42590250.000-36%55909916.667-51%123428200.000-78%129654246.300-79%
Usd Book Value Change Per Share---0.815-0.179-78%-1.235+52%0.042-2047%-0.181-78%-0.190-77%
Usd Book Value Per Share--3.5533.966-10%5.576-36%5.240-32%5.353-34%5.711-38%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--92158978.000127160552.500-28%66863096.001+38%107732309.990-14%250701305.017-63%392509483.669-77%
Usd Eps---1.155-1.307+13%-1.681+46%-1.529+32%-1.135-2%-0.930-19%
Usd Free Cash Flow---23439000.000-14051500.000-40%6884500.000-440%-9105083.333-61%-13657473.500-42%-12460886.700-47%
Usd Free Cash Flow Per Share---3.069-1.840-40%0.901-440%-0.845-72%-0.699-77%-0.586-81%
Usd Free Cash Flow To Equity Per Share---2.817-0.813-71%1.207-333%-0.346-88%-0.326-88%118.226-102%
Usd Market Cap143204062.500+49%73014978.000103488802.500-29%30846346.001+137%61213309.990+19%157037905.017-54%306256262.869-76%
Usd Price Per Share18.750+49%9.56013.550-29%4.039+137%6.353+50%6.920+38%13.934-31%
Usd Profit---8818000.000-9979500.000+13%-12838750.000+46%-14873416.667+69%-18342650.000+108%-17256799.750+96%
Usd Revenue--9419000.0008038500.000+17%3237000.000+191%3758500.000+151%6319000.000+49%4256143.750+121%
Usd Total Gains Per Share---0.815-0.179-78%-1.235+52%0.042-2047%-0.181-78%-0.190-77%
 EOD+5 -3MRQTTM+12 -26YOY+16 -223Y+9 -295Y+10 -2810Y+10 -28

3.3 Fundamental Score

Let's check the fundamental score of Assembly Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.060
Price to Book Ratio (EOD)Between0-15.278
Net Profit Margin (MRQ)Greater than0-0.936
Operating Margin (MRQ)Greater than0-1.055
Quick Ratio (MRQ)Greater than13.402
Current Ratio (MRQ)Greater than12.049
Debt to Asset Ratio (MRQ)Less than10.726
Debt to Equity Ratio (MRQ)Less than12.649
Return on Equity (MRQ)Greater than0.15-0.325
Return on Assets (MRQ)Greater than0.05-0.089
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Assembly Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5065.837
Ma 20Greater thanMa 5017.672
Ma 50Greater thanMa 10015.408
Ma 100Greater thanMa 20013.107
OpenGreater thanClose18.240
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Assembly Biosciences Inc

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5336 and ABI-1179, which are in Phase 1a/1b clinical studies for recurrent genital herpes; ABI-4334, a capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus that is in Phase 1b clinical study; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study. The company also develops ABI-7423, an oral broad-spectrum non-nucleoside polymerase inhibitor that targets transplant-related herpesviruses. It has an option, license, and collaboration agreement with Gilead Sciences, Inc. for the research and development of virology therapies. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Fundamental data was last updated by Penke on 2025-07-10 21:13:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Assembly Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Assembly Biosciences Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -93.6%Β means thatΒ $-0.94 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Assembly Biosciences Inc:

  • The MRQ is -93.6%. The company is making a huge loss. -2
  • The TTM is -126.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-93.6%TTM-126.3%+32.7%
TTM-126.3%YOY-77.5%-48.8%
TTM-126.3%5Y-245.4%+119.1%
5Y-245.4%10Y-341.8%+96.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-93.6%-93.6%0.0%
TTM-126.3%-140.9%+14.6%
YOY-77.5%-197.6%+120.1%
3Y-67.9%-248.5%+180.6%
5Y-245.4%-343.4%+98.0%
10Y-341.8%-496.2%+154.4%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Assembly Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Assembly Biosciences Inc to theΒ Biotechnology industry mean.
  • -8.9% Return on Assets means thatΒ Assembly Biosciences Inc generatedΒ $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Assembly Biosciences Inc:

  • The MRQ is -8.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.9%TTM-9.2%+0.3%
TTM-9.2%YOY-17.2%+8.0%
TTM-9.2%5Y-13.5%+4.3%
5Y-13.5%10Y-11.3%-2.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.9%-11.6%+2.7%
TTM-9.2%-11.6%+2.4%
YOY-17.2%-11.4%-5.8%
3Y-15.4%-11.8%-3.6%
5Y-13.5%-12.0%-1.5%
10Y-11.3%-13.7%+2.4%
4.3.1.3. Return on Equity

Shows how efficient Assembly Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Assembly Biosciences Inc to theΒ Biotechnology industry mean.
  • -32.5% Return on Equity means Assembly Biosciences Inc generated $-0.32Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Assembly Biosciences Inc:

  • The MRQ is -32.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -33.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-32.5%TTM-33.2%+0.7%
TTM-33.2%YOY-30.0%-3.2%
TTM-33.2%5Y-22.1%-11.0%
5Y-22.1%10Y-17.7%-4.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-32.5%-13.5%-19.0%
TTM-33.2%-14.9%-18.3%
YOY-30.0%-14.6%-15.4%
3Y-28.9%-16.8%-12.1%
5Y-22.1%-17.5%-4.6%
10Y-17.7%-19.9%+2.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Assembly Biosciences Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Assembly Biosciences Inc is operatingΒ .

  • Measures how much profit Assembly Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Assembly Biosciences Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of -105.5%Β means the company generated $-1.06 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Assembly Biosciences Inc:

  • The MRQ is -105.5%. The company is operating very inefficient. -2
  • The TTM is -141.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-105.5%TTM-141.3%+35.8%
TTM-141.3%YOY-90.2%-51.2%
TTM-141.3%5Y-251.2%+109.9%
5Y-251.2%10Y-355.6%+104.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-105.5%-232.5%+127.0%
TTM-141.3%-250.5%+109.2%
YOY-90.2%-209.2%+119.0%
3Y-77.2%-234.1%+156.9%
5Y-251.2%-346.1%+94.9%
10Y-355.6%-477.5%+121.9%
4.3.2.2. Operating Ratio

Measures how efficient Assembly Biosciences Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 2.06 means that the operating costs are $2.06 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Assembly Biosciences Inc:

  • The MRQ is 2.055. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.414. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.055TTM2.414-0.359
TTM2.414YOY1.402+1.013
TTM2.4145Y4.590-2.176
5Y4.59010Y6.810-2.219
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0552.111-0.056
TTM2.4142.694-0.280
YOY1.4023.096-1.694
3Y1.2723.652-2.380
5Y4.5904.745-0.155
10Y6.8106.614+0.196
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Assembly Biosciences Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Assembly Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 2.05Β means the company has $2.05 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Assembly Biosciences Inc:

  • The MRQ is 2.049. The company is able to pay all its short-term debts. +1
  • The TTM is 2.390. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.049TTM2.390-0.341
TTM2.390YOY5.164-2.774
TTM2.3905Y8.093-5.703
5Y8.09310Y10.174-2.082
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0493.661-1.612
TTM2.3903.846-1.456
YOY5.1644.140+1.024
3Y4.9934.688+0.305
5Y8.0935.746+2.347
10Y10.1746.147+4.027
4.4.3.2. Quick Ratio

Measures if Assembly Biosciences Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Assembly Biosciences Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 3.40Β means the company can pay off $3.40 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Assembly Biosciences Inc:

  • The MRQ is 3.402. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.001. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.402TTM4.001-0.599
TTM4.001YOY7.965-3.964
TTM4.0015Y12.637-8.636
5Y12.63710Y15.643-3.006
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4022.848+0.554
TTM4.0013.169+0.832
YOY7.9653.786+4.179
3Y7.4724.311+3.161
5Y12.6375.703+6.934
10Y15.6436.368+9.275
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Assembly Biosciences Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Assembly Biosciences IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Assembly Biosciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.73Β means that Assembly Biosciences Inc assets areΒ financed with 72.6% credit (debt) and the remaining percentage (100% - 72.6%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Assembly Biosciences Inc:

  • The MRQ is 0.726. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.721. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.726TTM0.721+0.004
TTM0.721YOY0.449+0.273
TTM0.7215Y0.311+0.411
5Y0.31110Y0.286+0.025
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7260.329+0.397
TTM0.7210.349+0.372
YOY0.4490.331+0.118
3Y0.4430.340+0.103
5Y0.3110.349-0.038
10Y0.2860.379-0.093
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Assembly Biosciences Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Assembly Biosciences Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 264.9% means that company has $2.65 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Assembly Biosciences Inc:

  • The MRQ is 2.649. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.601. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.649TTM2.601+0.049
TTM2.601YOY1.368+1.233
TTM2.6015Y0.883+1.718
5Y0.88310Y0.651+0.231
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6490.379+2.270
TTM2.6010.437+2.164
YOY1.3680.414+0.954
3Y1.3860.450+0.936
5Y0.8830.464+0.419
10Y0.6510.515+0.136
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Assembly Biosciences Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Assembly Biosciences Inc to theΒ Biotechnology industry mean.
  • A PE ratio of -2.07 means the investor is paying $-2.07Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Assembly Biosciences Inc:

  • The EOD is -4.060. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.070. Based on the earnings, the company is expensive. -2
  • The TTM is -2.585. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.060MRQ-2.070-1.990
MRQ-2.070TTM-2.585+0.515
TTM-2.585YOY-0.797-1.788
TTM-2.5855Y-1.894-0.692
5Y-1.89410Y-5.928+4.035
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.060-2.356-1.704
MRQ-2.070-2.077+0.007
TTM-2.585-2.574-0.011
YOY-0.797-3.760+2.963
3Y-1.302-3.773+2.471
5Y-1.894-6.193+4.299
10Y-5.928-6.876+0.948
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Assembly Biosciences Inc:

  • The EOD is -1.527. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.779. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -19.559. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.527MRQ-0.779-0.749
MRQ-0.779TTM-19.559+18.780
TTM-19.559YOY-0.410-19.148
TTM-19.5595Y-4.389-15.170
5Y-4.38910Y-6.302+1.913
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.527-3.246+1.719
MRQ-0.779-2.705+1.926
TTM-19.559-3.704-15.855
YOY-0.410-4.402+3.992
3Y-6.874-5.070-1.804
5Y-4.389-8.477+4.088
10Y-6.302-9.305+3.003
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Assembly Biosciences Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 2.69 means the investor is paying $2.69Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Assembly Biosciences Inc:

  • The EOD is 5.278. Based on the equity, the company is overpriced. -1
  • The MRQ is 2.691. Based on the equity, the company is underpriced. +1
  • The TTM is 3.443. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.278MRQ2.691+2.587
MRQ2.691TTM3.443-0.752
TTM3.443YOY0.898+2.545
TTM3.4435Y1.452+1.991
5Y1.45210Y2.750-1.297
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.2782.038+3.240
MRQ2.6911.843+0.848
TTM3.4432.125+1.318
YOY0.8982.442-1.544
3Y1.5972.492-0.895
5Y1.4523.652-2.200
10Y2.7504.311-1.561
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Assembly Biosciences Inc.

4.8.1. Institutions holding Assembly Biosciences Inc

Institutions are holding 12.773% of the shares of Assembly Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Vanguard Group Inc2.82790215983155257.7448
2025-03-31B Group, Inc2.61861.6379200000149349294.8589
2025-03-31Renaissance Technologies Corp1.48360.00161133111860019.6387
2025-03-31BlackRock Inc1.0342078988-2541-3.1167
2025-03-31Geode Capital Management, LLC0.624604770310682.2901
2025-03-31MONIMUS CAPITAL MANAGEMENT, LP0.55080.34144206700
2025-03-31Northern Trust Corp0.3708028323-326-1.1379
2025-03-31Federated Hermes Inc0.33250.00052539400
2025-03-31Armistice Capital, LLC0.31240.003423858-144216-85.8051
2025-03-31Acadian Asset Management LLC0.30150.000623027230270
2025-03-31Squarepoint Ops LLC0.24850.000218982189820
2025-03-31Marshall Wace Asset Management Ltd0.23620.000218040321721.7028
2025-03-31Palumbo Wealth Management LLC0.23550.057517986655957.3991
2025-03-31Man Group PLC0.2350.000417952-1615-8.2537
2025-03-31Susquehanna International Group, LLP0.228017414-4040-18.831
2025-03-31Bridgeway Capital Management, LLC0.19930.00371522512008.5561
2025-03-31State Street Corp0.183401400900
2025-03-31Citadel Advisors Llc0.1605012258122580
2025-03-31American Century Companies Inc0.15450.000111799117990
2025-03-31Connor Clark & Lunn Inv Mgmt Ltd0.13330.000410182-631-5.8356
Total 12.47112.0479952501+108215+11.4%

4.9.2. Funds holding Assembly Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-05-31Vanguard Total Stock Mkt Idx Inv1.70610.000113030700
2025-05-31Vanguard Institutional Extnd Mkt Idx Tr0.86880.00096635600
2025-03-31Federated Hermes MDT SCG Institutional0.33250.05442539400
2025-03-31Federated Hermes MDT Small Cap Growth IS0.33250.05432539400
2025-04-30Fidelity Extended Market Index0.30060.000722956-219-0.945
2025-03-31Vanguard Strategic Small-Cap Equity Inv0.23210.01041772300
2025-03-31Bridgeway Ultra-Small Company Market0.180.13421375000
2025-05-31Avantis US Small Cap Value ETF0.12920.00099871-199-1.9762
2025-04-30Fidelity Total Market Index0.11190.0001854400
2025-05-31iShares Micro-Cap ETF0.09290.013709600
2025-04-30Fidelity Series Total Market Index0.07840.000159873255.74
2025-03-31Northern Small Cap Core I0.07790.01615953-247-3.9839
2025-03-31Northern Trust Extended Eq Market Idx0.0660.0006504100
2025-03-31NT Ext Equity Mkt Idx Fd - L0.0660.0006504100
2025-03-31Extended Equity Market Fund K0.06510.00044970150.3027
2025-04-30Spartan Extended Market Index Pool F0.05860.000744762195.1445
2025-03-31Fidelity VIP Disciplined Small Cap Init0.05250.0093401300
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.0520.0006396900
2025-04-30Fidelity Nasdaq Composite Index0.04090.0002312300
2025-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.04050.00063090-56-1.78
Total 4.88450.2982373054-1620.0%

5.3. Insider Transactions

Insiders are holding 39.246% of the shares of Assembly Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-03-31Jason A OkazakiSELL3559.85
2025-03-31Jeanette M BjorkquistSELL1809.85
2025-03-31John G MchutchisonSELL7579.85
2024-12-30Michael HoughtonBUY320215.61
2024-11-18Nicole S WhiteSELL4016.29
2024-10-08Alexander SchornsteinBUY1000014.58
2024-10-03Jason A OkazakiSELL19714.81
2024-10-03Nicole S WhiteSELL15714.81
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets99,017
Total Liabilities71,884
Total Stockholder Equity27,133
 As reported
Total Liabilities 71,884
Total Stockholder Equity+ 27,133
Total Assets = 99,017

Assets

Total Assets99,017
Total Current Assets95,527
Long-term Assets3,490
Total Current Assets
Cash And Cash Equivalents 23,413
Short-term Investments 67,615
Other Current Assets 4,499
Total Current Assets  (as reported)95,527
Total Current Assets  (calculated)95,527
+/-0
Long-term Assets
Property Plant Equipment 3,178
Long-term Assets Other 312
Long-term Assets  (as reported)3,490
Long-term Assets  (calculated)3,490
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities46,631
Long-term Liabilities25,253
Total Stockholder Equity27,133
Total Current Liabilities
Short-term Debt 529
Accounts payable 875
Other Current Liabilities 3,533
Total Current Liabilities  (as reported)46,631
Total Current Liabilities  (calculated)4,937
+/- 41,694
Long-term Liabilities
Capital Lease Obligations 3,020
Long-term Liabilities  (as reported)25,253
Long-term Liabilities  (calculated)3,020
+/- 22,233
Total Stockholder Equity
Common Stock8
Retained Earnings -834,743
Accumulated Other Comprehensive Income -253
Other Stockholders Equity 862,121
Total Stockholder Equity (as reported)27,133
Total Stockholder Equity (calculated)27,133
+/-0
Other
Capital Stock8
Cash and Short Term Investments 91,028
Common Stock Shares Outstanding 7,506
Current Deferred Revenue40,819
Liabilities and Stockholders Equity 99,017
Net Debt -20,393
Net Invested Capital 27,133
Net Working Capital 48,896
Property Plant and Equipment Gross 3,178
Short Long Term Debt Total 3,020



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-31
> Total Assets 
870
0
0
0
166
1,425
1,156
579
14,617
14,138
11,524
53,388
37,046
31,390
29,010
23,679
20,556
37,103
33,677
32,365
27,132
23,904
21,755
60,394
71,225
138,347
144,707
139,654
133,744
124,454
117,206
109,127
98,119
134,284
122,775
112,313
169,303
156,021
142,418
282,977
268,045
259,247
241,511
223,345
339,907
313,310
294,801
306,306
283,254
278,903
262,136
248,973
191,060
162,730
143,447
121,516
101,794
83,116
66,577
51,629
137,469
119,883
115,323
100,262
119,168
99,017
99,017119,168100,262115,323119,883137,46951,62966,57783,116101,794121,516143,447162,730191,060248,973262,136278,903283,254306,306294,801313,310339,907223,345241,511259,247268,045282,977142,418156,021169,303112,313122,775134,28498,119109,127117,206124,454133,744139,654144,707138,34771,22560,39421,75523,90427,13232,36533,67737,10320,55623,67929,01031,39037,04653,38811,52414,13814,6175791,1561,425166000870
   > Total Current Assets 
0
0
0
0
84
1,069
655
275
14,590
14,102
11,466
53,379
37,038
31,383
29,001
23,671
20,549
37,097
33,667
32,358
27,125
23,896
21,748
18,080
29,216
96,338
71,333
66,503
68,368
59,089
64,103
59,255
53,575
92,222
77,669
68,652
123,119
113,226
97,529
239,873
222,502
200,806
183,460
165,322
282,780
256,752
235,088
246,387
224,493
221,634
205,558
188,219
154,204
130,777
124,294
115,078
96,967
79,744
64,081
49,672
133,787
117,168
112,931
98,213
115,503
95,527
95,527115,50398,213112,931117,168133,78749,67264,08179,74496,967115,078124,294130,777154,204188,219205,558221,634224,493246,387235,088256,752282,780165,322183,460200,806222,502239,87397,529113,226123,11968,65277,66992,22253,57559,25564,10359,08968,36866,50371,33396,33829,21618,08021,74823,89627,12532,35833,66737,09720,54923,67129,00131,38337,03853,37911,46614,10214,5902756551,069840000
       Cash And Cash Equivalents 
16
0
0
0
81
1,068
650
271
14,571
14,001
11,369
53,294
36,975
31,067
28,844
23,560
20,489
36,874
33,490
32,223
27,061
23,637
21,316
17,933
29,091
96,054
53,518
36,401
27,108
20,395
20,341
23,794
28,575
70,818
39,453
27,247
82,033
66,927
54,192
119,752
41,471
29,107
34,258
24,867
46,732
42,326
96,709
58,311
59,444
78,253
59,517
70,760
45,627
51,174
43,063
54,673
52,418
43,482
21,623
26,656
19,841
18,749
19,208
28,452
38,344
23,413
23,41338,34428,45219,20818,74919,84126,65621,62343,48252,41854,67343,06351,17445,62770,76059,51778,25359,44458,31196,70942,32646,73224,86734,25829,10741,471119,75254,19266,92782,03327,24739,45370,81828,57523,79420,34120,39527,10836,40153,51896,05429,09117,93321,31623,63727,06132,22333,49036,87420,48923,56028,84431,06736,97553,29411,36914,00114,5712716501,0688100016
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,209
29,396
40,557
37,928
43,205
34,851
24,388
20,105
36,124
39,053
37,914
42,232
38,480
114,188
176,609
164,429
139,553
132,070
227,311
206,803
130,005
179,630
156,969
136,631
139,560
110,142
101,000
71,826
73,626
53,978
39,192
29,534
38,208
19,554
110,406
94,227
90,011
66,502
73,735
67,615
67,61573,73566,50290,01194,227110,40619,55438,20829,53439,19253,97873,62671,826101,000110,142139,560136,631156,969179,630130,005206,803227,311132,070139,553164,429176,609114,18838,48042,23237,91439,05336,12420,10524,38834,85143,20537,92840,55729,39617,20900000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
260
0
0
0
0
0
0
0
0
0
0
0
1,114
1,400
2,274
2,264
2,126
2,590
2,430
2,987
2,903
2,944
3,374
3,055
3,315
3,590
1,230
203
297
769
336
524
523
1,246
944
717
342
100
43
43
400
0
0
0
00040043431003427179441,2465235243367692972031,2303,5903,3153,0553,3742,9442,9032,9872,4302,5902,1262,2642,2741,4001,114000000000002600000000000000000000000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-100
0
0
0
0
0
0
000000-10000000000000000000000000000000000000000000000000000000000000
   > Long-term Assets 
0
0
0
0
82
356
501
304
27
36
58
9
8
7
9
8
7
6
9
8
7
8
7
42,314
42,009
42,009
73,374
73,151
65,376
65,365
53,103
49,872
44,544
42,063
45,106
43,661
46,185
42,795
44,889
43,104
45,543
58,441
58,051
58,023
57,127
56,558
59,713
59,919
58,761
57,269
56,578
60,754
36,856
31,953
19,153
6,438
4,827
3,372
2,496
1,957
3,682
2,715
2,392
2,049
3,665
3,490
3,4903,6652,0492,3922,7153,6821,9572,4963,3724,8276,43819,15331,95336,85660,75456,57857,26958,76159,91959,71356,55857,12758,02358,05158,44145,54343,10444,88942,79546,18543,66145,10642,06344,54449,87253,10365,36565,37673,15173,37442,00942,00942,314787896789789583627304501356820000
       Property Plant Equipment 
17
0
0
0
13
11
10
9
0
11
10
9
8
7
9
8
7
6
9
8
7
8
7
34
156
173
174
156
149
132
114
128
215
183
132
593
860
732
640
516
557
15,142
14,720
14,714
13,805
13,259
12,843
12,301
10,731
9,597
8,847
8,014
7,181
6,319
5,610
4,825
3,938
3,038
2,164
1,405
2,724
2,403
2,080
1,737
3,353
3,178
3,1783,3531,7372,0802,4032,7241,4052,1643,0383,9384,8255,6106,3197,1818,0148,8479,59710,73112,30112,84313,25913,80514,71414,72015,1425575166407328605931321832151281141321491561741731563478789678978910110910111300017
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,143
12,737
12,737
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000012,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,73712,73712,14300000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31,437
31,186
23,392
23,390
11,167
7,900
2,436
0
0
0
3,347
0
2,204
0
0
0
0
0
0
0
0
0
0
0
0
9,180
27,972
23,459
11,908
0
0
0
0
0
0
0
0
0
0
0
0000000000011,90823,45927,9729,1800000000000002,20403,3470002,4367,90011,16723,39023,39231,18631,43700000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,137
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00030,13700000000000000000000000
       Long-term Assets Other 
0
0
0
0
70
345
491
295
27
25
48
0
0
0
0
0
0
0
0
0
0
0
0
0
115
99
125
170
197
204
184
205
255
242
327
426
340
426
407
951
3,348
1,661
1,693
1,671
1,684
1,661
5,232
5,980
6,392
6,034
6,093
1,922
1,703
2,175
1,635
1,613
78
334
332
552
312
312
312
312
312
312
312312312312312312552332334781,6131,6352,1751,7031,9226,0936,0346,3925,9805,2321,6611,6841,6711,6931,6613,348951407426340426327242255205184204197170125991150000000000000482527295491345700000
> Total Liabilities 
10,327
0
0
0
13,529
14,924
16,224
17,536
2,990
1,606
2,090
1,183
2,513
3,853
3,392
2,681
2,745
1,977
2,585
2,318
2,638
1,462
1,470
13,192
12,654
13,728
13,840
14,252
15,003
15,169
16,645
19,082
18,241
66,396
66,240
65,180
56,184
53,640
53,318
53,544
57,392
68,846
66,804
66,856
66,690
61,542
27,686
35,757
42,676
31,659
30,342
24,328
22,131
15,939
19,467
19,112
19,130
12,783
11,628
9,915
96,372
87,282
80,641
74,259
85,809
71,884
71,88485,80974,25980,64187,28296,3729,91511,62812,78319,13019,11219,46715,93922,13124,32830,34231,65942,67635,75727,68661,54266,69066,85666,80468,84657,39253,54453,31853,64056,18465,18066,24066,39618,24119,08216,64515,16915,00314,25213,84013,72812,65413,1921,4701,4622,6382,3182,5851,9772,7452,6813,3923,8532,5131,1832,0901,6062,99017,53616,22414,92413,52900010,327
   > Total Current Liabilities 
4,712
0
0
0
12,357
13,729
15,000
16,290
1,720
310
770
1,183
2,513
3,853
3,392
2,681
2,745
1,977
2,585
2,318
2,638
1,462
1,470
1,049
1,054
2,128
2,240
2,652
3,403
3,569
5,045
7,482
7,121
10,957
11,989
12,219
13,492
12,180
13,131
14,610
18,472
25,205
19,935
21,498
24,440
21,146
17,271
16,804
24,433
14,497
13,910
14,928
16,073
10,709
14,961
15,461
16,296
9,970
8,831
7,132
39,225
38,753
41,274
41,635
47,803
46,631
46,63147,80341,63541,27438,75339,2257,1328,8319,97016,29615,46114,96110,70916,07314,92813,91014,49724,43316,80417,27121,14624,44021,49819,93525,20518,47214,61013,13112,18013,49212,21911,98910,9577,1217,4825,0453,5693,4032,6522,2402,1281,0541,0491,4701,4622,6382,3182,5851,9772,7452,6813,3923,8532,5131,1837703101,72016,29015,00013,72912,3570004,712
       Short-term Debt 
0
0
0
0
7,841
10,199
10,688
7,426
1,219
1,219
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,408
5,708
6,416
3,186
6,528
6,500
6,676
3,404
5,868
6,096
6,198
3,151
6,414
6,622
6,742
3,364
5,092
3,404
1,738
1,220
2,290
2,590
1,329
461
529
5294611,3292,5902,2901,2201,7383,4045,0923,3646,7426,6226,4143,1516,1986,0965,8683,4046,6766,5006,5283,1866,4165,7085,40800000000000000000000000000000001,2191,2197,42610,68810,1997,8410000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,704
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000002,70400000000000000000000000000000000000000000
       Accounts payable 
4,125
0
0
0
398
2,136
1,676
1,282
313
123
622
1,183
2,342
3,143
3,158
1,843
1,847
1,527
2,132
2,280
2,615
1,435
1,421
1,049
908
1,251
1,304
1,464
1,364
2,326
2,414
3,838
2,368
1,947
688
871
2,124
2,373
2,539
2,988
3,693
2,427
3,414
2,709
1,731
2,104
3,640
1,611
4,598
3,562
2,866
2,628
2,659
1,407
2,454
1,942
2,493
1,224
904
758
461
727
801
1,335
585
875
8755851,3358017274617589041,2242,4931,9422,4541,4072,6592,6282,8663,5624,5981,6113,6402,1041,7312,7093,4142,4273,6932,9882,5392,3732,1248716881,9472,3683,8382,4142,3261,3641,4641,3041,2519081,0491,4211,4352,6152,2802,1321,5271,8471,8433,1583,1432,3421,1836221233131,2821,6762,1363980004,125
       Other Current Liabilities 
417
0
0
0
4,119
1,394
2,636
7,582
188
188
148
0
171
710
234
838
898
449
454
37
23
27
48
1,049
146
878
936
1,187
2,039
1,243
2,631
3,644
4,753
4,014
6,306
6,353
11,368
4,647
5,080
6,517
9,679
7,437
4,731
6,222
13,112
5,799
7,131
8,517
16,431
5,067
4,948
6,102
10,263
2,888
5,885
6,777
10,439
3,654
4,523
4,636
6,629
2,965
4,823
6,351
9,135
3,533
3,5339,1356,3514,8232,9656,6294,6364,5233,65410,4396,7775,8852,88810,2636,1024,9485,06716,4318,5177,1315,79913,1126,2224,7317,4379,6796,5175,0804,64711,3686,3536,3064,0144,7533,6442,6311,2432,0391,1879368781461,0494827233745444989883823471017101481881887,5822,6361,3944,119000417
   > Long-term Liabilities 
0
0
0
0
1,171
1,195
1,224
1,246
1,271
1,295
1,320
0
0
0
0
0
898,213
0
0
0
23,435
0
0
12,143
11,600
11,600
11,600
11,600
11,600
11,600
11,600
11,600
11,120
55,439
54,250
52,961
42,692
41,460
40,187
38,934
38,920
43,641
46,869
45,358
42,250
40,396
10,415
18,953
18,243
17,162
16,432
9,400
6,058
5,230
4,506
3,651
2,834
2,813
2,797
2,783
57,147
48,529
39,367
32,624
38,006
25,253
25,25338,00632,62439,36748,52957,1472,7832,7972,8132,8343,6514,5065,2306,0589,40016,43217,16218,24318,95310,41540,39642,25045,35846,86943,64138,92038,93440,18741,46042,69252,96154,25055,43911,12011,60011,60011,60011,60011,60011,60011,60011,60012,1430023,435000898,213000001,3201,2951,2711,2461,2241,1951,1710000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,600
0
0
0
11,600
0
0
0
11,120
44,319
43,075
41,815
40,555
41,460
40,187
38,934
38,920
33,120
36,834
35,519
33,168
31,857
2,531
11,518
11,518
11,518
11,518
5,264
2,733
2,733
2,733
2,733
0
0
2,733
0
0
0
0
0
0
0
00000002,733002,7332,7332,7332,7335,26411,51811,51811,51811,5182,53131,85733,16835,51936,83433,12038,92038,93440,18741,46040,55541,81543,07544,31911,12000011,60000011,600000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,600
11,600
11,600
0
55,439
54,250
52,961
0
41,460
40,187
38,934
38,920
0
36,834
3,251
2,531
2,531
2,531
2,531
2,531
2,531
800
2,531
200
200
200
200
0
0
200
0
0
0
0
0
0
0
0000000200002002002002002,5318002,5312,5312,5312,5312,5312,5313,25136,834038,92038,93440,18741,460052,96154,25055,439011,60011,60011,60000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
-13,363
-13,499
-15,068
-16,957
11,626
12,532
9,434
52,205
34,533
27,537
25,619
20,998
17,810
35,126
31,091
30,048
24,494
22,442
20,285
47,202
58,571
124,619
130,867
125,402
118,742
109,285
100,561
90,045
79,878
67,888
56,535
47,133
113,120
102,381
89,101
229,433
210,653
190,401
174,707
156,489
273,217
251,768
267,115
270,549
240,578
247,244
231,794
224,645
168,929
146,791
123,980
102,404
82,664
70,333
54,949
41,714
41,097
32,601
34,682
26,003
33,359
27,133
27,13333,35926,00334,68232,60141,09741,71454,94970,33382,664102,404123,980146,791168,929224,645231,794247,244240,578270,549267,115251,768273,217156,489174,707190,401210,653229,43389,101102,381113,12047,13356,53567,88879,87890,045100,561109,285118,742125,402130,867124,61958,57147,20220,28522,44224,49430,04831,09135,12617,81020,99825,61927,53734,53352,2059,43412,53211,626-16,957-15,068-13,499-13,3630000
   Common Stock
0
0
0
0
0
6
6
0
7
7
7
12
12
12
13
13
13
20
20
21
21
23
5
9
11
16
17
17
17
17
17
17
17
17
17
17
20
20
21
25
25
26
26
26
32
32
33
33
34
40
44
47
48
48
48
48
49
52
52
53
5
5
6
6
7
8
87665553525249484848484744403433333232262626252521202017171717171717171717161195232121202013131312121277706600000
   Retained Earnings Total Equity00000000-743,470-724,520-702,125-678,980-654,5190-571,171-552,368-528,773-501,573-462,155-458,806-466,076-439,421-412,337-387,342-368,839-341,787-315,626-294,091-267,285-251,036-248,029-235,757-222,158-208,227-196,681-185,107-174,954-163,966-156,218-149,600-142,657-135,512-129,283-118,262-115,793-111,723-105,676-100,794-96,043-92,320-88,528-83,173-75,703-67,529-48,670-42,8680000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-15
0
0
0
-27
-27
0
0
-28
-28
0
0
-33
0
369
369
-39
369
369
369
0
-64
-134
-388
-822
-749
-839
-837
-601
-525
-398
-388
-392
-459
-372
-355
-347
-239
-187
-205
-201
-86
104
-158
-270
-271
-273
-288
-419
-908
-998
-999
-803
-513
-325
-275
-81
-239
-293
-156
-211
-253
-253-211-156-293-239-81-275-325-513-803-999-998-908-419-288-273-271-270-158104-86-201-205-187-239-347-355-372-459-392-388-398-525-601-837-839-749-822-388-134-640369369369-393693690-3300-28-2800-27-27000-150000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
52,295
100,862
102,049
103,228
108,779
109,514
110,117
131,149
131,497
135,334
135,828
137,843
138,174
176,108
194,073
267,260
280,584
281,991
283,512
284,972
286,490
287,545
288,689
290,554
292,673
295,533
364,528
370,105
383,543
545,389
552,762
559,453
562,210
569,005
712,807
717,898
725,784
732,829
742,387
776,248
784,391
796,057
0
802,170
803,910
805,480
807,938
814,264
0
0
0
0
0
0
0
0
00000000814,264807,938805,480803,910802,1700796,057784,391776,248742,387732,829725,784717,898712,807569,005562,210559,453552,762545,389383,543370,105364,528295,533292,673290,554288,689287,545286,490284,972283,512281,991280,584267,260194,073176,108138,174137,843135,828135,334131,497131,149110,117109,514108,779103,228102,049100,86252,2950000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
4,545
6,410
6,969
6,861
44,831
48,432
52,295
100,862
102,049
103,228
108,779
109,514
110,117
131,149
131,866
135,334
135,844
137,843
138,174
176,108
194,073
267,260
280,584
281,991
283,512
284,972
286,490
287,545
288,689
290,554
292,673
295,533
364,528
370,105
383,543
545,389
552,762
559,453
562,210
569,005
712,807
717,898
725,784
732,829
742,387
776,248
784,391
796,057
800,728
802,170
803,910
805,480
807,938
814,264
815,588
816,722
826,921
827,660
840,946
841,743
859,488
862,121
862,121859,488841,743840,946827,660826,921816,722815,588814,264807,938805,480803,910802,170800,728796,057784,391776,248742,387732,829725,784717,898712,807569,005562,210559,453552,762545,389383,543370,105364,528295,533292,673290,554288,689287,545286,490284,972283,512281,991280,584267,260194,073176,108138,174137,843135,844135,334131,866131,149110,117109,514108,779103,228102,049100,86252,29548,43244,8316,8616,9696,4104,5450000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue28,520
Cost of Revenue-129
Gross Profit28,39128,391
 
Operating Income (+$)
Gross Profit28,391
Operating Expense-73,940
Operating Income-45,420-45,549
 
Operating Expense (+$)
Research Development55,933
Selling General Administrative18,007
Selling And Marketing Expenses0
Operating Expense73,94073,940
 
Net Interest Income (+$)
Interest Income5,573
Interest Expense-0
Other Finance Cost-0
Net Interest Income5,573
 
Pretax Income (+$)
Operating Income-45,420
Net Interest Income5,573
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-39,847-50,993
EBIT - interestExpense = -45,549
-39,847
-40,177
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-45,549-39,847
Earnings Before Interest and Taxes (EBITDA)-45,420
 
After tax Income (+$)
Income Before Tax-39,847
Tax Provision-330
Net Income From Continuing Ops-40,177-40,177
Net Income-40,177
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses73,940
Total Other Income/Expenses Net5,573-5,573
 

Technical Analysis of Assembly Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Assembly Biosciences Inc. The general trend of Assembly Biosciences Inc is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Assembly Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Assembly Biosciences Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Assembly Biosciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 18.98 < 19.93 < 20.04.

The bearish price targets are: 18.05 > 18.00 > 14.80.

Know someone who trades $ASMB? Share this with them.πŸ‘‡

Assembly Biosciences Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Assembly Biosciences Inc. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Assembly Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Assembly Biosciences Inc. The current macd is 0.9021986.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Assembly Biosciences Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Assembly Biosciences Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Assembly Biosciences Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Assembly Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartAssembly Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Assembly Biosciences Inc. The current adx is 39.78.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Assembly Biosciences Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Assembly Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Assembly Biosciences Inc. The current sar is 17.61.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Assembly Biosciences Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Assembly Biosciences Inc. The current rsi is 65.84. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Assembly Biosciences Inc Daily Relative Strength Index (RSI) ChartAssembly Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Assembly Biosciences Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Assembly Biosciences Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Assembly Biosciences Inc Daily Stochastic Oscillator ChartAssembly Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Assembly Biosciences Inc. The current cci is 120.09.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Assembly Biosciences Inc Daily Commodity Channel Index (CCI) ChartAssembly Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Assembly Biosciences Inc. The current cmo is 29.78.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Assembly Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartAssembly Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Assembly Biosciences Inc. The current willr is -15.57632399.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Assembly Biosciences Inc Daily Williams %R ChartAssembly Biosciences Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Assembly Biosciences Inc.

Assembly Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Assembly Biosciences Inc. The current atr is 0.87132959.

Assembly Biosciences Inc Daily Average True Range (ATR) ChartAssembly Biosciences Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Assembly Biosciences Inc. The current obv is 5,777,227.

Assembly Biosciences Inc Daily On-Balance Volume (OBV) ChartAssembly Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Assembly Biosciences Inc. The current mfi is 57.13.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Assembly Biosciences Inc Daily Money Flow Index (MFI) ChartAssembly Biosciences Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Assembly Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-29BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-07MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-07-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Assembly Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Assembly Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5065.837
Ma 20Greater thanMa 5017.672
Ma 50Greater thanMa 10015.408
Ma 100Greater thanMa 20013.107
OpenGreater thanClose18.240
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Assembly Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Assembly Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Assembly Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Assembly Biosciences Inc

I send you an email if I find something interesting about Assembly Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Assembly Biosciences Inc.

Receive notifications about Assembly Biosciences Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.